EyeGene Market Cap

EyeGene has a market cap or net worth of 58.19 billion as of June 29, 2026. Its market cap has decreased by -36.12% in one year.

Market Cap

58.19B

Enterprise Value

16.06B

Revenue

4.02B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,346.00

Market Cap Chart

Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 58.19B, a decrease of -55.58%. That is a compound annual growth rate of -7.35%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	58.19B	-22.60%
Dec 30, 2025	75.18B	8.64%
Dec 30, 2024	69.20B	-24.46%
Dec 28, 2023	91.61B	-15.21%
Dec 29, 2022	108.04B	-73.58%
Dec 30, 2021	408.92B	175.32%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BIO-FD&C	68.17B
CTCBIO	66.23B
ADBiotech	66.03B
QuadMedicine	63.27B
Naturalendo Tech	59.45B
PanGen Biotech	58.52B
KoBioLabs	56.90B
IMGT Co.,Ltd.	56.24B

Market Cap Rankings